Jacob
Senior Member
- Reaction score
- 44
TB4?
Panacea Biotec in-licenses novel technology from NIH for hair growth
Source: IRIS (09 August 2005)
Panacea Biotec (Q, N,C,F)* Ltd has in licensed a peptide based technology for alopecia management from the National Institute of Health, USA. The patent protected technology for actin- binding peptide(s)/poly peptide(s) stimulates hair growth and regenerates lost hair follicles.
The ability of hair follicles to constantly renew is ensured by the presence of the multipotent stem cell. This peptide(s) appears to stimulate multipotent stem cells at the `bulge region`.
The Company will undertake further development of the technology and the company is initiating the preclinical toxicology studies for which the appropriate formulation has already been prepared. After receiving the necessary regulatory approvals for the toxicology data that will be generated, the company will undertake human clinical trials for the product.
Shares of Panacea Biotec on BSE were lastly traded at Rs 229, up by 1.82 per cent.
http://www.myiris.com/newsCentre/newsPo ... D=livenews[/quote]
Panacea Biotec in-licenses novel technology from NIH for hair growth
Source: IRIS (09 August 2005)
Panacea Biotec (Q, N,C,F)* Ltd has in licensed a peptide based technology for alopecia management from the National Institute of Health, USA. The patent protected technology for actin- binding peptide(s)/poly peptide(s) stimulates hair growth and regenerates lost hair follicles.
The ability of hair follicles to constantly renew is ensured by the presence of the multipotent stem cell. This peptide(s) appears to stimulate multipotent stem cells at the `bulge region`.
The Company will undertake further development of the technology and the company is initiating the preclinical toxicology studies for which the appropriate formulation has already been prepared. After receiving the necessary regulatory approvals for the toxicology data that will be generated, the company will undertake human clinical trials for the product.
Shares of Panacea Biotec on BSE were lastly traded at Rs 229, up by 1.82 per cent.
http://www.myiris.com/newsCentre/newsPo ... D=livenews[/quote]